Works citing this work

3 works

Work: Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy

1. Engineering CAR T NK and NKT cell therapies to target cancer stem cells and overcome stem like resistance

   Omer Qutaiba B. Allela, Abdulkareem Shareef, S. Renuka Jyothi +9

   ArticleCAR-T cell therapy researchDiscover Oncology20250 citations

   ABIABI:AkademIndex/openalex/2025.article.001466

2. Therapeutic targeting of cancer stem cell-specific surface glycans and glycoproteins

   Mutaz Jamal Al-khreisat, Waleed K. Abdulsahib, Ihsan Khudhair Jasim +6

   ArticleGlycosylation and Glycoproteins ResearchDiscover Oncology20260 citations

   ABIABI:AkademIndex/openalex/2026.article.003592

3. Synthetic lethality and DNA damage response targeting in cancer stem cells: a comprehensive review

   Usamah Sayed, Waleed K. Abdulsahib, Ihsan Khudhair Jasim +6

   ArticleCancer Cells and MetastasisDiscover Oncology20260 citations

   ABIABI:AkademIndex/openalex/2026.article.003910